Empyrean Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$147M |
| 2 |
AGN
Allergan plc
AGN
|
+$142M |
| 3 |
Liberty Global Class C
LBTYK
|
+$97.3M |
| 4 |
Eagle Materials
EXP
|
+$80.4M |
| 5 |
AABA
Altaba Inc
AABA
|
+$78.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$118M |
| 2 |
Elanco Animal Health
ELAN
|
+$79.3M |
| 3 |
Coty
COTY
|
+$51.8M |
| 4 |
Equitable Holdings
EQH
|
+$48.1M |
| 5 |
Walt Disney
DIS
|
+$19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 15.33% |
| 2 | Healthcare | 13.98% |
| 3 | Technology | 9.68% |
| 4 | Communication Services | 8.83% |
| 5 | Real Estate | 5.09% |
Similar funds
Empyrean Capital Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Empyrean Capital Partners held 97 positions worth $2.25B, up 2.5% from $2.19B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Empyrean Capital Partners withdrew a net $267M in Q2 2019, closing 19 positions and reducing 6 holdings. Its most notable exit was Air Products & Chemicals, an estimated $118M position sold in full.
By sector, the portfolio is most concentrated in Materials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Empyrean Capital Partners opened a new position in Anadarko Petroleum worth $154M.
- Empyrean Capital Partners's largest Q2 2019 buy was Anadarko Petroleum: 2,187,044 shares worth $154M.
- Empyrean Capital Partners added most to Liberty Global Class C in Q2 2019, an estimated $97.3M increase.
- Empyrean Capital Partners's biggest Q2 2019 reduction was Dell, cutting an estimated $10.6M.
- Empyrean Capital Partners fully exited Air Products & Chemicals in Q2 2019, selling an estimated $118M.
- Empyrean Capital Partners's ten largest holdings make up 60% of its $2.25B portfolio in Q2 2019.
- Empyrean Capital Partners opened 19 new positions and closed 19 in Q2 2019.
- Empyrean Capital Partners's portfolio value rose 2.5% quarter-over-quarter to $2.25B.
Based on Empyrean Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.